Last updated: 11/07/2018 15:19:41
A randomised double-blind placebo-controlled 3-way crossover study to investigate the effects of pre-treatment with single inhaled doses of GW559090X and fluticasone propionate on the allergen induced late phase asthmatic response in mild asthmatic subjects
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A randomised double-blind placebo-controlled 3-way crossover study to investigate the effects of pre-treatment with single inhaled doses of GW559090X and fluticasone propionate on the allergen induced late phase asthmatic response in mild asthmatic subjects
Trial description: A randomised double-blind placebo-controlled 3-way crossover study to investigate the effects of pre-treatment with single inhaled doses of GW559090X and fluticasone propionate on the allergen induced late phase asthmatic response in mild asthmatic subjects
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Ravensberg AJ, Luijk B, Westers P, van den Heuvel B, Jachtenberg E, Hiemstra PS, Sterk PJ, Lammers JW and Rabe KF. Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in mild asthma. Poster accepted at European Respiratory Society Congress, Copenhagen 2005.
Medical condition
Asthma
Product
GW559090, fluticasone propionate
Collaborators
Not applicable
Study date(s)
January 2003 to September 2003
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2003-03-09
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website